Myovant, Sumitomo Call Alleged Skadden Conflict Public Info
Executives of Sumitomo Pharma America Inc. and Myovant Sciences Ltd. have urged a New York federal judge to toss a proposed class action claiming the companies' merger was undervalued because lawyers...To view the full article, register now.
Already a subscriber? Click here to view full article